Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting

This study has been terminated.
Sponsor:
Information provided by:
Dynogen Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00252993
First received: November 11, 2005
Last updated: October 10, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: March 2006
  Estimated Primary Completion Date: No date given